USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis
NYSE:USNA - New York Stock Exchange, Inc. - US90328M1071 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to USNA. USNA was compared to 35 industry peers in the Personal Care Products industry. While USNA has a great health rating, its profitability is only average at the moment. USNA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year USNA was profitable.
USNA had a positive operating cash flow in the past year.
In the past 5 years USNA has always been profitable.
USNA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
USNA's Return On Assets of 4.67% is fine compared to the rest of the industry. USNA outperforms 68.57% of its industry peers.
With a decent Return On Equity value of 6.59%, USNA is doing good in the industry, outperforming 74.29% of the companies in the same industry.
USNA's Return On Invested Capital of 5.52% is in line compared to the rest of the industry. USNA outperforms 57.14% of its industry peers.
USNA had an Average Return On Invested Capital over the past 3 years of 10.32%. This is below the industry average of 15.14%.
The last Return On Invested Capital (5.52%) for USNA is well below the 3 year average (10.32%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.67% | ||
| ROE | 6.59% | ||
| ROIC | 5.52% |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
1.3 Margins
USNA's Profit Margin of 3.98% is fine compared to the rest of the industry. USNA outperforms 65.71% of its industry peers.
In the last couple of years the Profit Margin of USNA has declined.
The Operating Margin of USNA (6.54%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of USNA has declined.
USNA has a better Gross Margin (80.53%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of USNA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.54% | ||
| PM (TTM) | 3.98% | ||
| GM | 80.53% |
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so USNA is still creating some value.
USNA has less shares outstanding than it did 1 year ago.
USNA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, USNA has a worse debt to assets ratio.
2.2 Solvency
USNA has an Altman-Z score of 4.13. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
USNA's Altman-Z score of 4.13 is fine compared to the rest of the industry. USNA outperforms 65.71% of its industry peers.
USNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.13 |
ROIC/WACC0.63
WACC8.76%
2.3 Liquidity
A Current Ratio of 2.05 indicates that USNA has no problem at all paying its short term obligations.
USNA has a Current ratio of 2.05. This is comparable to the rest of the industry: USNA outperforms 60.00% of its industry peers.
USNA has a Quick Ratio of 1.51. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.51, USNA is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.51 |
3. Growth
3.1 Past
USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.05%.
The earnings per share for USNA have been decreasing by -10.07% on average. This is quite bad
The Revenue has decreased by -2.69% in the past year.
The Revenue has been decreasing by -4.23% on average over the past years.
EPS 1Y (TTM)-23.05%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-15.12%
Revenue 1Y (TTM)-2.69%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%9.54%
3.2 Future
The Earnings Per Share is expected to grow by 15.32% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.38% on average over the next years. This is quite good.
EPS Next Y2.39%
EPS Next 2Y15.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.44%
Revenue Next 2Y9.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.91, which indicates a correct valuation of USNA.
Compared to the rest of the industry, the Price/Earnings ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 82.86% of the companies listed in the same industry.
USNA is valuated cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.22 indicates a reasonable valuation of USNA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 88.57% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.70. USNA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.91 | ||
| Fwd PE | 9.22 |
4.2 Price Multiples
88.57% of the companies in the same industry are more expensive than USNA, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 5.35 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
USNA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as USNA's earnings are expected to grow with 15.32% in the coming years.
PEG (NY)5.4
PEG (5Y)N/A
EPS Next 2Y15.32%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for USNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
31.88
+1.35 (+4.42%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners58.81%
Inst Owner Change0.24%
Ins Owners0.58%
Ins Owner Change0.25%
Market Cap593.61M
Analysts43.33
Price Target62.22 (95.17%)
Short Float %9.59%
Short Ratio5.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.21%
Min EPS beat(2)2.24%
Max EPS beat(2)28.18%
EPS beat(4)3
Avg EPS beat(4)6.24%
Min EPS beat(4)-18.68%
Max EPS beat(4)28.18%
EPS beat(8)6
Avg EPS beat(8)16.14%
EPS beat(12)8
Avg EPS beat(12)17.2%
EPS beat(16)10
Avg EPS beat(16)12.1%
Revenue beat(2)2
Avg Revenue beat(2)0.47%
Min Revenue beat(2)0.28%
Max Revenue beat(2)0.66%
Revenue beat(4)2
Avg Revenue beat(4)-2.31%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)0.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.6%
Revenue beat(12)6
Avg Revenue beat(12)-0.96%
Revenue beat(16)8
Avg Revenue beat(16)-0.96%
PT rev (1m)0%
PT rev (3m)20.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.4%
EPS NY rev (1m)0%
EPS NY rev (3m)1.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.91 | ||
| Fwd PE | 9.22 | ||
| P/S | 0.68 | ||
| P/FCF | N/A | ||
| P/OCF | 10.1 | ||
| P/B | 1.12 | ||
| P/tB | 2.49 | ||
| EV/EBITDA | 5.35 |
EPS(TTM)2.47
EY7.75%
EPS(NY)3.46
Fwd EY10.85%
FCF(TTM)-8.28
FCFYN/A
OCF(TTM)3.16
OCFY9.9%
SpS47.06
BVpS28.45
TBVpS12.8
PEG (NY)5.4
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.67% | ||
| ROE | 6.59% | ||
| ROCE | 9.41% | ||
| ROIC | 5.52% | ||
| ROICexc | 7.83% | ||
| ROICexgc | 24.33% | ||
| OM | 6.54% | ||
| PM (TTM) | 3.98% | ||
| GM | 80.53% | ||
| FCFM | N/A |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexcg growth 3Y-27.3%
ROICexcg growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 1080.18% | ||
| Cap/Sales | 24.31% | ||
| Interest Coverage | 551.17 | ||
| Cash Conversion | 76.31% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.51 | ||
| Altman-Z | 4.13 |
F-Score5
WACC8.76%
ROIC/WACC0.63
Cap/Depr(3y)569.36%
Cap/Depr(5y)383.35%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.05%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-15.12%
EPS Next Y2.39%
EPS Next 2Y15.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.69%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%9.54%
Revenue Next Year11.44%
Revenue Next 2Y9.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.93%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year54.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-293.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.39%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%